Device Trial Radar · NCT02630914
Medical and Surgical Hybrid Treatment of Atrial Fibrillation.
Last checked: Nov 20, 2026Latest source record: Dec 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Sep 2015
Primary completion
Mar 2018
Study completion Mar 2018
Sponsor
- Lead sponsor
- University Hospital, ToulouseAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 15, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to investigate the feasibility of a hybrid procedure removal of the atrial fibrillation. This is a single procedure for both surgical epicardial by minimally invasive route (Thoracoscopy) without even flow controlled and supplemented if necessary by extra corporeal intracavitary route at the same time. This faster procedure combined with complete lesions have a higher success rate and less frequent re-hospitalizations of patients.
Conditions
- Atrial Fibrillation (AF)
Interventions
The AtriCure Synergy Ablation SystemDevice
The AtriCure Synergy Ablation System will be used on all patients for AF ablation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with complete procedure or notTime frame: 3 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospital Toulouse
Toulouse, Midi Pyrenees, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.